Amgen Inc.

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells (2018) Jitschin R, Saul D, Braun M, Tohumeken S, Kischel R, Lutteropp M, Dos Santos C, et al. Journal article Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial (2017) Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, Dokoupilova E, et al. Journal article Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass (2017) Genant HK, Engelke K, Bolognese MA, Mautalen C, Brown JP, Recknor C, Goemaere S, et al. Journal article Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass (2017) Keaveny TM, Crittenden DB, Bolognese MA, Genant HK, Engelke K, Oliveri B, Brown JP, et al. Journal article Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study (2016) Goebeler ME, Knop S, Viardot A, Kufer P, Topp MS, Einsele H, Noppeney R, et al. Journal article C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) (2016) Mc Causland FR, Claggett B, Burdmann EA, Eckardt KU, Kewalramani R, Levey AS, Mcmurray JJV, et al. Journal article Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus (2015) Lewis EF, Claggett B, Parfrey PS, Burdmann EA, Mcmurray JJV, Solomon SD, Levey AS, et al. Journal article Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology (2015) Zysset P, Pahr D, Engelke K, Genant HK, Mcclung MR, Kendler DL, Recknor C, et al. Journal article High cardiovascular event rates occur within the first weeks of starting hemodialysis (2015) Eckardt KU, Gillespie IA, Kronenberg F, Richards S, Stenvinkel P, Anker SD, Wheeler DC, et al. Journal article Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab (2014) Keaveny TM, Mcclung MR, Genant HK, Zanchetta JR, Kendler D, Brown JP, Goemaere S, et al. Journal article